St. Jude/Endocardial Solutions face J&J suit
This article was originally published in The Gray Sheet
Executive Summary
Endocardial Solutions CEO James Bullock questions the timing of Biosense Webster patent infringement suit. In an Oct. 15 statement, the exec notes Endocardial Solutions' EnSite system "has been in the U.S. market since 1999, but no lawsuit was filed until St. Jude Medical announced its intention to acquire Endocardial Solutions." St. Jude purchased the firm for $273 mil. in September to augment its atrial fibrillation division (1"The Gray Sheet" Sept. 27, 2004, p. 9). The suit, filed in Los Angeles district court, claims the EnSite mapping and navigation system and NavX surface electrodes infringe certain Johnson & Johnson patents...